PROTAC ER Degraders in ER-Positive/HER2-Negative MBC Progressing After Endocrine Therapy: Latest Updates From SABCS 2025

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Current and Emerging Clinical Data: Expert Insights to Optimize PROTAC ER Degraders

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Unlocking the Full Potential of PROTAC ER Degraders in ER+/HER2- MBC: Current Treatment Landscape and Unmet Needs for Patients 

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Unlocking the Full Potential of PROTAC ER Degraders in ER+/HER2- MBC: Novel Mechanisms, Testing Applications, and Data Insights to Address Unmet Needs

Content Format:

Slideset

Credit Type:

--

Credits:

--
Advancing Precision Care and Shared Decision-making in 1L HER2+ mBC Management: Expert Insights, Patient Resources, and Adaptive Decision Support

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
Advancing Precision Care and Shared Decision-making in 1L HER2+ mBC Management: Expert Insights, Patient Resources, and Adaptive Decision Support  

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

1.00
Newly Diagnosed HER2-Positive Metastatic Breast Cancer: Treatment Options and Key Considerations

Content Format:

PDF

Credit Type:

--

Credits:

--
Emerging Data for Ongoing Trials in First-Line mBC and Experts Recommendations for Addressing Clinical Challenges With ADCs

Content Format:

Slideset

Credit Type:

--

Credits:

--